Three Things Investors Look for Before Investing
MDMA Treatment for Alcoholism
Starting a business can be very expensive. Only a few lucky entrepreneurs manage to get the ball rolling without any external funding. Business owners are always on the lookout for the right connections, funding, and network, but at the end of the day, it’s not about how much you know. It’s all about how much you’ve got!
Issues Your Psychedelics Startups Will Face and How to Deal With Them Efficiently
Some of the most common psychedelic medicine used to treat alcohol addiction is MDMA and psilocybin mushroom. The field of psychedelic medicine used to treat mental health diagnoses and addiction is relatively new, but the studies being conducted show encouraging outcomes. This leads many entrepreneurs to invest in psychedelics ventures to help provide better treatment outcomes for those battling addiction.
Common Psychedelics Startup Problems: Everything You Need to Know
Over the past few years, entrepreneurs, investors, and stockholders from the business community have been keenly interested in the psychedelic medicine market. The market is expected to grow more than 10 billion by 2027. Psychedelic companies are working to make psychedelic medicine commercially accessible to treat conditions like PTSD, depression, and chronic pain. Creating a startup in today’s market is no smooth sailing, and working in an unconventional market for psychedelics is more complicated. Here are some […]
Can Psychedelic Therapy Help People Cope with Alzheimer’s Disease?
Starting a business startup is a big accomplishment; however, operating it successfully is the biggest test most business people fail. Over two-thirds of new startups fail, and end and most of these ventures end in the first three years. Operating in a psychedelic medicine industry can be very challenging due to the taboo around psychedelic drug use for treatment purposes. Although with evolving studies, people are becoming more open to the idea, however, many investors still […]
Alzheimer’s disease is one of the most prevalent cognitive diseases in the world with more than 30 million global cases. It affects your motor skills and function, memory and attention span, and self-control, causing a gradual cognitive decline.